China Diagnostic Imaging Equipment Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

China Diagnostic Imaging Equipment Market Trends and Insights

Rise In Prevalence Of Chronic Diseases

China recorded 3.25 million new cancer cases and 330 million cardiovascular patients in 2024, anchoring a vast, recurrent imaging requirement^{[1]National Cancer Center, “2024 Cancer Statistics Report,” cicams.ac.cn}. Annual low-dose CT for high-risk lung-cancer cohorts and 24/7 stroke-center CT availability hardwire imaging into clinical pathways. Procedure volumes underscore scale: 1.421 million percutaneous-coronary interventions and 1.539 million coronary angiographies in 2024 each demanded pre-procedural CT angiography or fluoroscopy guidance. Serial PET/CT for immunotherapy monitoring and iterative trauma follow-up sustain equipment utilization, while national oncology-screening guidelines institutionalize demand.

Growing Geriatric Population

Seniors aged 60 and above numbered 297 million (21.1% of population) in 2025 and will exceed 400 million by 2035. Multimorbidity among older adults drives orthopedic X-ray, brain MRI, and carotid ultrasound orders. The Healthy Aging Action Plan embeds imaging into preventive care, mandating annual mammography, low-dose lung CT, and ultrasound vascular checks. Provinces already above 20% elderly share are channeling subsidies into low-field MRI suites and portable ultrasound fleets to serve frail patients.

Government Equipment-Upgrade Subsidies & DRG Roll-Out

The State Council’s March 2024 upgrade initiative opened a CNY 5 trillion (USD 700 billion) domestic replacement pool, reimbursing half the sticker price for qualifying China-made devices. Diagnosis-Related Group (DRG) payments reward high-throughput scanners that cut length of stay; hospitals rushing to meet DRG cost ceilings now prefer dual-energy CT and AI-assisted MRI that reduce rescans. Subsidies skew procurement toward United Imaging, Mindray, and Neusoft, reshaping competitive order.

AI-Driven Productivity Gains Easing Radiologist Shortage

Radiologist density remains 1.5 per 10,000 people, far below the U.S. benchmark of 4.2. Fifty-nine NMPA-cleared AI algorithms cut reading time by 30%–50% and lift diagnostic accuracy up to 15%, enabling radiologists to process 20%–30% more studies per shift. Vendors bundle AI subscriptions—Siemens’ AI-Rad Companion, GE’s Edison—with scanners, converting one-off hardware deals into annuity revenue.

High acquisition and lifetime ownership costs

Buying a top tier scanner is expensive. A 3-Tesla MRI or a photon-counting CT typically costs more than USD 1 million, and the bills do not end there. When hospitals add ten years of service contracts, consumables and room renovations, the total spend can reach three times the sticker price. County hospitals feel this squeeze the most because their per-bed budgets are roughly one-third of what large urban centers can spend. Day-to-day running costs add fresh pressure. A standard MRI magnet uses about 1,500 liters of liquid helium each year, and with prices at CNY 200 (USD 28) per liter the annual helium bill alone is nearly CNY 300,000 (USD 42,000). Philips introduced a helium-free 1.5-Tesla MRI in 2025 that removes this expense, yet the unit itself is priced about 15% higher than older helium-based models. Flexible financing would help, but fewer than 10% of Chinese scanners are leased, compared with roughly 30% in Western Europe, so smaller institutions have limited options. Government subsidies offset part of the upfront price, however the programs favor domestic brands and exclude refurbished systems, which narrows choice and keeps aging fleets in service longer.

Radiation and contrast-agent safety concerns

Regulators set dose reference levels for every CT exam, yet a 2024 audit found that 18% of scans still exceeded the limits, most often in pediatric and emergency cases where protocols are harder to tailor. Repeated exposure adds up. Cancer patients and trauma victims who undergo many follow-up studies face a higher lifetime radiation risk, so the National Health Commission released new guidelines that emphasize iterative reconstruction and automatic exposure control to keep doses low. Contrast media bring their own issues. Iodinated dyes used in CT angiography cause kidney injury in 2%–5% of patients, especially those who are elderly or have diabetes, and evidence of gadolinium deposits in the brain prompted an advisory to switch from linear to macrocyclic MRI agents. Hospitals are turning to spectral CT and AI denoising software that allow lower kilovoltage or fewer projections, but the extra validation work and higher purchase prices slow adoption. Legal exposure is also rising. Malpractice claims linked to contrast reactions grew 12% in 2024, so many procurement teams now wait for longer safety data before upgrading scanners, which lengthens replacement cycles.

Segment Analysis

By Modality: Photon-Counting CT And Ultra-High-Field MRI Redefine Premium Tiers

CT captured 35.55% of the China diagnostic imaging equipment market share in 2025 as photon-counting technology elevates diagnostic precision^{[2]National Medical Products Administration, “2024 Annual Device Registration Report,” nmpa.gov.cn}. High-slice and spectral capabilities compress scan times from 15 to 8 minutes, freeing capacity and lowering DRG costs. MRI is projected to grow at a 10.25% CAGR, with ultra-high-field platforms revealing microstructural pathology that 1.5-Tesla systems miss. Siemens’ new 7-Tesla MRI and Philips’ multinuclear MR7700 are piloting cardiology and neurology protocols. Low-field MRI continues serving claustrophobic or pediatric cohorts, maintaining balanced modality mix. 

Second paragraph elaborates on ultrasound, X-ray, nuclear medicine, and fluoroscopy, noting that digital radiography commands 85% of new installs, while PET growth tracks novel tracer approvals. Dual-modality PET/CT fills oncology and cardiology gaps, and 3-D breast tomosynthesis meets dose-optimization rules. Vendors that pair modality hardware with AI analytics defend margins against commoditizing mid-range segments.

Note: Segment shares of all individual segments available upon report purchase

By Portability: Handheld Ultrasound Disrupts Fixed-System Economics

Fixed scanners held 60.53% of the China diagnostic imaging equipment market size in 2025, but handheld and mobile platforms are poised for a 10.75% CAGR through 2031. Residency curricula mandating point-of-care ultrasound generate 5,000 newly certified users each year, expanding orders for Butterfly iQ+ and Mindray Resona handhelds. 

Hospitals still rely on fixed 3-Tesla MRI suites that process 25 patients daily at scale, while mobile CT trailers service rural screening and disaster relief. Modular designs such as GE’s Venue series let providers migrate from cart-based to pocket-sized probes without workflow upheaval.

By Application: Emergency Medicine Outpaces Oncology Growth

Oncology retained 22.15% share in 2025, yet emergency medicine will rise fastest at 10.82% CAGR as stroke-center standards require sub-20-minute door-to-imaging times. County hospitals failing audits are procuring dual-source CT and rapid-sequence MRI to comply, enlarging the China diagnostic imaging equipment market. 

Cardiology shifts toward coronary CT angiography, while neurology expands with dementia imaging and amyloid-PET adoption. Orthopedics, gastroenterology, and obstetrics round out diversified demand; 3-D/4-D prenatal ultrasound volumes continue climbing under updated fetal-imaging protocols.

Note: Segment shares of all individual segments available upon report purchase

By End User: Diagnostic Imaging Centers Gain Private-Capital Momentum

Hospitals contributed 67.65% of 2025 spending, but private imaging centers are scaling 8.32% annually on radiology-as-a-service models. Independent chains offer chest CT for CNY 300 versus hospital rates of CNY 500, leveraging extended hours and AI triage to cut wait times from 2 weeks to 3 days. 

DRG reform that equalizes reimbursement across venues will accelerate volume migration to centers equipped with photon-counting CT and 3-Tesla MRI. Tele-radiology partnerships blur boundaries: county hospitals own scanners yet outsource reads to city-based centers, expanding the China diagnostic imaging equipment industry ecosystem.

Geography Analysis

Eastern provinces deploy 6.4 CT scanners per million residents versus 2.1 in western regions, mirroring MRI gaps of 3.8 to 1.2 units. Tier-1 cities host Siemens Naeotom Alpha and GE Revolution Apex installations, funded by DRG efficiency gains. Tier-2 strongholds such as Hangzhou and Chengdu gravitate toward lower-priced domestic photon-counting CT that undercuts imports by 30%. 

Western provinces receive CNY 10 billion in subsidies for 64-slice CT and 1.5-Tesla MRI, yet procurement plus training stretches impact to 2026-plus. Central provinces bridge extremes, relying on AI algorithms to offset radiologist shortages. Coastal Zhejiang pilots AI imaging reimbursement at CNY 50–100 per study, paving the way for national adoption and geographically balancing demand.